SCHEMBL4698483

SCHEMBL4698483

NC(=O)C1=CNC(OC(=O)C(F)(F)F)=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4699656 0.74 — —
SCHEMBL5729041 0.71 — —
SCHEMBL28045655 0.71 — —
SCHEMBL27971076 0.69 — —
SCHEMBL16962385 0.63 — —
Trifluoroacetic Acid SCHEMBL4698480 0.63 — —
Trifluoroacetic Acid SCHEMBL4698207 0.63 — —
SCHEMBL3099782 0.59 — —
SCHEMBL28756727 0.57 MAP2K1 (0.31) —
SCHEMBL3641757 0.57 KMT2A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987037-A2 FUSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-11-05 — — EP disclosed
WO-2007097470-A2 FUSED NITROGEN- COMPRISING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-30 — — WO disclosed
Send feedback